Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara E Meyer

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Blood|March 23, 2023
Context is key for FLT3-ITDSara E Meyer
Blood|January 28, 2017
From EMT to HSC to AML: ZEB2 is a cell fate switchSara E Meyer
Blood|January 17, 2020
MicroRNA immunomodulating therapeuticsSara E Meyer
Blood|August 19, 2017
Splicing together the origins of MDS-RSSara E Meyer
Blood|February 21, 2015
A 2-way miRror of red blood cells and leukemiaH Leighton Grimes, Sara E Meyer
Current Opinion in Hematology|November 13, 2020
Genetic heterogeneity and clonal evolution in acute myeloid leukemiaJennifer S Romer-Seibert, Sara E Meyer
Journal of Cellular Physiology|May 14, 2011
MicroRNAs in the midst of myeloid signal transductionSara L Stoffers, Sara E Meyer, H Leighton Grimes
Molecular Carcinogenesis|May 20, 2009
The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) miceSara E Meyer, Susan E Waltz, Kathleen H Goss
Developmental Biology|July 7, 2009
The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesisSara E Meyer, Glendon M Zinser, William D Stuart, et al.
Leukemia|November 23, 2024
miR-196b-Oct1/2 axis regulates DNMT3A-mutant AML pathogenesisMichael E Lawler, Melanie L Goetz, Jennifer S Romer-Seibert, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Blood|March 23, 2023
Context is key for FLT3-ITDSara E Meyer
Blood|January 28, 2017
From EMT to HSC to AML: ZEB2 is a cell fate switchSara E Meyer
Blood|January 17, 2020
MicroRNA immunomodulating therapeuticsSara E Meyer
Blood|August 19, 2017
Splicing together the origins of MDS-RSSara E Meyer
Blood|February 21, 2015
A 2-way miRror of red blood cells and leukemiaH Leighton Grimes, Sara E Meyer
Current Opinion in Hematology|November 13, 2020
Genetic heterogeneity and clonal evolution in acute myeloid leukemiaJennifer S Romer-Seibert, Sara E Meyer
Journal of Cellular Physiology|May 14, 2011
MicroRNAs in the midst of myeloid signal transductionSara L Stoffers, Sara E Meyer, H Leighton Grimes
Molecular Carcinogenesis|May 20, 2009
The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) miceSara E Meyer, Susan E Waltz, Kathleen H Goss
Developmental Biology|July 7, 2009
The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesisSara E Meyer, Glendon M Zinser, William D Stuart, et al.
Leukemia|November 23, 2024
miR-196b-Oct1/2 axis regulates DNMT3A-mutant AML pathogenesisMichael E Lawler, Melanie L Goetz, Jennifer S Romer-Seibert, et al.
Pageof 3